ArticleVaccine2017
Rotavirus immunization: Global coverage and local barriers for implementation.
Article in Vaccine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05212935 (A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Rotavirus vaccine coverage, completion, and compliance: A systematic literature review.Human vaccines & immunotherapeutics · 2025Pooled it
- Unlocking the power of probiotics, postbiotics: targeting apoptosis for the treatment and prevention of digestive diseases.Frontiers in nutrition · 2025Review
- Acute Infectious Diarrhea.Advances in experimental medicine and biology · 2024Review
- Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule.Human vaccines & immunotherapeutics · 2022Article
- Spatial distribution of rotavirus immunization coverage in Ethiopia: a geospatial analysis using the Bayesian approach.BMC infectious diseases · 2022Article
- Article
- Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections.Microorganisms · 2021Review
- Effect of childhood rotavirus vaccination on community rotavirus prevalence in rural Ecuador, 2008-13.International journal of epidemiology · 2020Article
- Rotavirus vaccination for all children or subgroups only? Comment of the European Academy of Paediatrics (EAP) and the European Society for Paediatric Infectious Diseases (ESPID) recommendation group for rotavirus vaccination.European journal of pediatrics · 2020Article
- Acute Gastroenteritis in Children of the World: What Needs to Be Done?Journal of pediatric gastroenterology and nutrition · 2020Article
- Role of healthcare practitioners in rotavirus disease awareness and vaccination - insights from a survey among caregivers.Human vaccines & immunotherapeutics · 2020Article
- Gene-edited vero cells as rotavirus vaccine substrates.Vaccine: X · 2019Article
- One drug to treat them all: ethical implications of the MORDOR trial of mass antibiotic administration to reduce child mortality.Journal of global health · 2019Review
- Rotavirus Infection and Vaccination: Knowledge, Beliefs, and Behaviors among Parents in Italy.International journal of environmental research and public health · 2019Article
- Universal Recommendations for the Management of Acute Diarrhea in Nonmalnourished Children.Journal of pediatric gastroenterology and nutrition · 2018Article
- Pediatric Dehydration Assessment at Triage: Prospective Study on Refilling Time.Pediatric gastroenterology, hepatology & nutrition · 2018Article
- Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC).Human vaccines & immunotherapeutics · 2018Article
- Antibiotic treatment of acute gastroenteritis in children.F1000Research · 2018Review
- Economic evaluation of routine infant rotavirus immunisation program in Japan.Human vaccines & immunotherapeutics · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundRotavirus (RV) is a major agent of gastroenteritis and an important cause of child death worldwide. Immunization (RVI) has been available since 2006, and the Federation of International Societies of Gastroenterology Hepatology and Nutrition (FISPGHAN) identified RVI as a top priority for the control of diarrheal illness. A FISPGHAN working group on acute diarrhea aimed at estimating the current RVI coverage worldwide and identifying barriers to implementation at local level.
methodsA survey was distributed to national experts in infectious diseases and health-care authorities (March 2015-April 2016), collecting information on local recommendations, costs and perception of barriers for implementation.
resultsForty-nine of the 79 contacted countries (62% response rate) provided a complete analyzable data. RVI was recommended in 27/49 countries (55%). Although five countries have recommended RVI since 2006, a large number (16, 33%) included RVI in a National Immunization Schedule between 2012 and 2014. The costs of vaccination are covered by the government (39%), by the GAVI Alliance (10%) or public and private insurance (8%) in some countries. However, in most cases, immunization is paid by families (43%). Elevated cost of vaccine (49%) is the main barrier for implementation of RVI. High costs of vaccination (rs=-0.39, p=0.02) and coverage of expenses by families (rs=0.5, p=0.002) significantly correlate with a lower immunization rate. Limited perception of RV illness severity by the families (47%), public-health authorities (37%) or physicians (24%) and the timing of administration (16%) are further major barriers to large- scale RVI programs.
conclusionsAfter 10years since its introduction, the implementation of RVI is still unacceptably low and should remain a major target for global public health. Barriers to implementation vary according to setting. Nevertheless, public health authorities should promote education for caregivers and health-care providers and interact with local health authorities in order to implement RVI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.